Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
NVIDIA
NVDA
|
$7.3B |
| 2 |
Eli Lilly
LLY
|
$3.9B |
| 3 |
Starbucks
SBUX
|
$3.78B |
| 4 |
Arista Networks
ANET
|
$1.4B |
| 5 |
Dominion Energy
D
|
$1.23B |
Top Sells
| 1 |
UnitedHealth
UNH
|
$4.7B |
| 2 |
Gilead Sciences
GILD
|
$2.61B |
| 3 |
Salesforce
CRM
|
$2.56B |
| 4 |
GE HealthCare
GEHC
|
$2.31B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$1.77B |
Sector Composition
| 1 | Technology | 29.16% |
| 2 | Consumer Discretionary | 13.59% |
| 3 | Healthcare | 12.72% |
| 4 | Industrials | 11.43% |
| 5 | Financials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BA.PRA
376
The Boeing Company Depositary Shares, each representing a 1/20th interest in a share of 6.00% Series A Mandatory Convertible Preferred Stock, par value $1.00
BA.PRA
$8.56B
| $27.6M | 0.01% | 406,339 -1,315,017 | -76% | -$89.4M |
|
377
Analog Devices
ADI
$124B
| $27.6M | 0.01% | 115,873 -167,685 | -59% | -$39.9M |
|
378
Cellebrite
CLBT
$4.01B
| $27.3M | 0.01% | 1,704,582 +1,241,592 | +268% | +$19.9M |
|
379
Louisiana-Pacific
LPX
$6.62B
| $27M | 0.01% | +313,497 | New | +$27M |
|
380
Enliven Therapeutics
ELVN
$1.2B
| $26.4M | 0.01% | +1,315,465 | New | +$26.4M |
|
381
Blue Owl Capital
OWL
$12.1B
| $25.1M | 0.01% | 1,308,550 +5,828 | +0.4% | +$112K |
|
|
STRZ
382
Starz Entertainment Corp. Common Shares
STRZ
$214M
| $23.9M | ﹤0.01% | +1,488,612 | New | +$23.9M |
|
383
Prestige Consumer Healthcare
PBH
$3.35B
| $23.6M | ﹤0.01% | +295,910 | New | +$23.6M |
|
384
Ezcorp Inc
EZPW
$1.02B
| $23.4M | ﹤0.01% | +1,682,664 | New | +$23.4M |
|
385
Royal Bank of Canada
RY
$205B
| $23M | ﹤0.01% | 174,560 +1,124 | +0.6% | +$148K |
|
386
Cadre Holdings
CDRE
$1.25B
| $22.7M | ﹤0.01% | 712,454 | – | – |
|
387
Herc Holdings
HRI
$4.35B
| $22.5M | ﹤0.01% | 170,649 | – | – |
|
388
NexGen Energy
NXE
$4.5B
| $22M | ﹤0.01% | 3,164,318 +726,489 | +30% | +$5.04M |
|
|
VOYG
389
Voyager Technologies, Inc.
VOYG
$1.81B
| $21.7M | ﹤0.01% | +553,226 | New | +$21.7M |
|
390
BioMarin Pharmaceuticals
BMRN
$11.2B
| $21.5M | ﹤0.01% | 391,879 -8,758,776 | -96% | -$481M |
|
|
BRSL
391
Brightstar Lottery PLC
BRSL
$3.15B
| $21.2M | ﹤0.01% | 1,340,155 +2,682 | +0.2% | +$42.4K |
|
392
ASP Isotopes
ASPI
$853M
| $21.1M | ﹤0.01% | 2,868,062 | – | – |
|
393
Denison Mines
DNN
$2.08B
| $20.9M | ﹤0.01% | 11,455,935 +2,626,749 | +30% | +$4.8M |
|
|
CHX
394
DELISTED
ChampionX
CHX
| $20.1M | ﹤0.01% | 809,902 -534,213 | -40% | -$13.3M |
|
395
Victoria's Secret
VSCO
$1.84B
| $19.4M | ﹤0.01% | 1,046,905 | – | – |
|
396
Freshpet
FRPT
$2.72B
| $18.8M | ﹤0.01% | 276,681 | – | – |
|
397
MongoDB
MDB
$25.7B
| $18.1M | ﹤0.01% | 86,170 -295,535 | -77% | -$62.1M |
|
398
Mueller Industries
MLI
$10.6B
| $15.2M | ﹤0.01% | +191,845 | New | +$15.2M |
|
399
Target
TGT
$43.6B
| $14.9M | ﹤0.01% | 150,848 | – | – |
|
400
Icon
ICLR
$13.8B
| $14.1M | ﹤0.01% | 97,083 -10,832 | -10% | -$1.58M |
|